The EXPAND study results: Safety and tolerability of siponimod in patients with secondary progressive multiple sclerosis

被引：0

作者：

Giovannoni, G. ^{[1
]}

Bar-or, A. ^{[2
]}

Cree, B. ^{[3
]}

Fox, R. ^{[4
]}

Gold, R. ^{[5
]}

Vermersch, P. ^{[6
]}

Pohlmann, H. ^{[7
]}

Wallstrom, E. ^{[7
]}

Wolf, C. ^{[8
]}

Dahlke, F. ^{[7
]}

Sidorenko, T. ^{[7
]}

Kappos, L. ^{[9
,10
,11
,12
]}

机构：

[1] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England

[2] McGill Univ, Montreal Neurol Inst & Hosp, Neuroimmunol Unit, Montreal, PQ, Canada

[3] Univ Calif San Francisco, Multiple Sclerosis Ctr, San Francisco, CA 94143 USA

[4] Cleveland Clin, Neurol Inst, Mellen Ctr Treatment & Res Multiple Sclerosis, Cleveland, OH 44106 USA

[5] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany

[6] Univ Lille, Dept Neurol, Lille, France

[7] Novartis Pharma AG, Basel, Switzerland

[8] Lycalis Sprl, Brussels, Belgium

[9] Univ Hosp Basel, Neurol Clin & Policlin, Dept Med, Basel, Switzerland

[10] Univ Hosp Basel, Neurol Clin & Policlin, Dept Clin Res, Basel, Switzerland

[11] Univ Hosp Basel, Neurol Clin & Policlin, Dept Biomed, Basel, Switzerland

[12] Univ Hosp Basel, Neurol Clin & Policlin, Dept Biomed Engn, Basel, Switzerland

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2017年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

PR1088

引用

页码：495 / 495

页数：1

共 50 条

[1] Safety and Tolerability of Siponimod in Patients with Secondary Progressive Multiple Sclerosis
Fox, Robert
Kappos, Ludwig
Bar-Or, Amit
Cree, Bruce
Giovannoni, Gavin
Gold, Ralf
Vermersch, Patrick
Pohlmann, Harold
Wolf, Christian
Dahlke, Frank
Wallstrom, Erik
Sidorenko, Tatiana
[J]. NEUROLOGY, 2017, 88
[2] The EXPAND study results: Efficacy of siponimod in secondary progressive multiple sclerosis
Vermersch, P.
Bar-Or, A.
Cree, B.
Fox, R.
Giovannoni, G.
Gold, R.
Arnould, S.
Wallstroem, E.
Sidorenko, T.
Wolf, C.
Dahlke, F.
Kappos, L.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 44 - 44
[3] Effects of siponimod on MRI outcomes in patients with secondary progressive multiple sclerosis: results of the phase 3 EXPAND study
Fox, R.
Arnold, D. L.
Bar-Or, A.
Cree, B.
Giovannoni, G.
Gold, R.
Vermersch, P.
Pohlmann, H.
Sidorenko, T.
Wolf, C.
Tomic, D.
Dahlke, F.
Kappos, L.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 34 - 35
[4] Impact of Siponimod on Cognition in Patients With Secondary Progressive Multiple Sclerosis: Results From Phase 3 EXPAND Study
Benedict, Ralph H. B.
Cree, Bruce
Tomic, Davorka
Fox, Robert
Giovannoni, Gavin
Bar-Or, Amit
Gold, Ralf
Vermersch, Patrick
Pohlmann, Harald
Karlsson, Goril
Dahlke, Frank
Kappos, Ludwig
[J]. NEUROLOGY, 2018, 90
[5] Siponimod and Cognition in Secondary Progressive Multiple Sclerosis EXPAND Secondary Analyses
Benedict, Ralph H. B.
Tomic, Davorka
Cree, Bruce A.
Fox, Robert
Giovannoni, Gavin
Bar-Or, Amit
Gold, Ralf
Vermersch, Patrick
Pohlmann, Harald
Wright, Ian
Karlsson, Goril
Dahlke, Frank
Wolf, Christian
Kappos, Ludwig
[J]. NEUROLOGY, 2021, 96 (03) : E376 - E386
[6] Effect of siponimod on cortical grey matter and thalamic volume in patients with secondary progressive multiple sclerosis - results of the EXPAND study
Arnold, D. L.
Fox, R.
Bar-Or, A.
Cree, B. A. C.
Giovannoni, G.
Gold, R.
Vermersch, P.
Meier, D. Piani
Arnould, S.
Ritter, S.
Dahlke, F.
Tomic, D.
Kappos, L.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 151 - 152
[7] Analyses of the effect of baseline age on the efficacy and safety of siponimod in patients with active secondary progressive multiple sclerosis from the EXPAND study
Hua, L. H.
Bar-Or, A.
Lublin, F. D.
Meng, X.
Cox, G. M.
Cree, B. Ac
Fox, R. J.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 551 - 552
[8] Efficacy of Siponimod in secondary progressive multiple sclerosis patients with active disease: the EXPAND study subgroup analysis
Gold, R.
Kappos, L.
Bar-Or, A.
Vermersch, P.
Giovannoni, G.
Fox, R.
Rouyrre, N.
Karlsson, G.
Cree, B. A. C.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 380 - 381
[9] Safety and efficacy of siponimod in patients with active secondary progressive multiple sclerosis identifying as Hispanic from the phase 3 EXPAND study
Cohan, S.
Hua, L. H.
Bar-Or, A.
Lublin, F. D.
Meng, X.
Cox, G. M.
Coyle, P. K.
Fox, R. J.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 590 - 591
[10] Magnetization Transfer Imaging in Secondary Progressive Multiple Sclerosis Patients Treated with Siponimod: Results from the Phase 3 EXPAND Study
Arnold, Douglas L.
Cree, Bruce A. C.
Bar-Or, Amit
Giovannoni, Gavin
Gold, Ralf
Vermersch, Patrick
Meier, Daniela Piani
Arnould, Sophie
Ritter, Shannon
Karlsson, Goeril
Kappos, Ludwig
Fox, Robert
[J]. NEUROLOGY, 2020, 94 (15)

← 1 2 3 4 5 →